174 related articles for article (PubMed ID: 17147886)
81. Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript.
Kwon BS; Jung HS; Song MS; Cho KS; Kim SC; Kimm K; Jeong JS; Kim IH; Lee SW
Mol Ther; 2005 Nov; 12(5):824-34. PubMed ID: 16040278
[TBL] [Abstract][Full Text] [Related]
82. Targeted gene therapy toward astrocytoma using a Cre/loxP-based adenovirus system.
Maeda M; Namikawa K; Kobayashi I; Ohba N; Takahara Y; Kadono C; Tanaka A; Kiyama H
Brain Res; 2006 Apr; 1081(1):34-43. PubMed ID: 16529724
[TBL] [Abstract][Full Text] [Related]
83. Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer.
van der Linden RR; Haagmans BL; Mongiat-Artus P; van Doornum GJ; Kraaij R; Kadmon D; Aguilar-Cordova E; Osterhaus AD; van der Kwast TH; Bangma CH
Eur Urol; 2005 Jul; 48(1):153-61. PubMed ID: 15967266
[TBL] [Abstract][Full Text] [Related]
84. [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma].
Chen J; Liu XS; Wang F; Xue XC; Fang GE; Su CQ; Qian QJ
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1372-6. PubMed ID: 19671324
[TBL] [Abstract][Full Text] [Related]
85. Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter.
Takeda T; Inaba H; Yamazaki M; Kyo S; Miyamoto T; Suzuki S; Ehara T; Kakizawa T; Hara M; DeGroot LJ; Hashizume K
J Clin Endocrinol Metab; 2003 Aug; 88(8):3531-8. PubMed ID: 12915632
[TBL] [Abstract][Full Text] [Related]
86. Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatment.
Uchino J; Takayama K; Harada A; Kawakami Y; Inoue H; Curiel DT; Nakanishi Y
Cancer Gene Ther; 2005 Sep; 12(9):737-48. PubMed ID: 15861179
[TBL] [Abstract][Full Text] [Related]
87. eIF4E-targeted suicide gene therapy in a minimal residual mouse model for metastatic soft-tissue head and neck squamous cell carcinoma improves disease-free survival.
Siegele B; Cefalu C; Holm N; Sun G; Tubbs J; Meschonat C; Odaka Y; DeBenedetti A; Ghali GE; Chu Q; Mathis JM; Li BD
J Surg Res; 2008 Jul; 148(1):83-9. PubMed ID: 18570935
[TBL] [Abstract][Full Text] [Related]
88. Carboxyl-terminal repressor domain of MBP-1 is sufficient for regression of prostate tumor growth in nude mice.
Ghosh AK; Steele R; Ray RB
Cancer Res; 2005 Feb; 65(3):718-21. PubMed ID: 15705866
[TBL] [Abstract][Full Text] [Related]
89. [Adenovirus-mediated CDglyTK fusion gene system driven by KDR promoter selectively kills colorectal cancer cells].
Lin RK; Huang ZH; Su GQ; Ke ZY; Chen JX; Zhou JJ
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):524-7. PubMed ID: 15897124
[TBL] [Abstract][Full Text] [Related]
90. Inhibition of telomerase with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells.
Gao XD; Chen YR
Asian J Androl; 2007 Sep; 9(5):697-704. PubMed ID: 17712489
[TBL] [Abstract][Full Text] [Related]
91. Combinatory gene therapy with electrotransfer of midkine promoter-HSV-TK and interleukin-21.
Hanari N; Matsubara H; Hoshino I; Akutsu Y; Nishimori T; Murakami K; Sakata H; Miyazawa Y; Ochiai T
Anticancer Res; 2007; 27(4B):2305-10. PubMed ID: 17695518
[TBL] [Abstract][Full Text] [Related]
92. Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy.
Li X; Liu YH; Lee SJ; Gardner TA; Jeng MH; Kao C
Clin Cancer Res; 2008 Jan; 14(1):291-9. PubMed ID: 18172281
[TBL] [Abstract][Full Text] [Related]
93. Potent anti-tumor activity of telomerase-dependent and HSV-TK armed oncolytic adenovirus for non-small cell lung cancer in vitro and in vivo.
Zhang JF; Wei F; Wang HP; Li HM; Qiu W; Ren PK; Chen XF; Huang Q
J Exp Clin Cancer Res; 2010 May; 29(1):52. PubMed ID: 20487549
[TBL] [Abstract][Full Text] [Related]
94. Novel, chimeric, cancer-specific, and radiation-inducible gene promoters for suicide gene therapy of cancer.
Xiong J; Sun WJ; Wang WF; Liao ZK; Zhou FX; Kong HY; Xu Y; Xie CH; Zhou YF
Cancer; 2012 Jan; 118(2):536-48. PubMed ID: 21717442
[TBL] [Abstract][Full Text] [Related]
95. HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer.
Lifang Y; Min T; Midan A; Ya C
J Exp Clin Cancer Res; 2008 Sep; 27(1):42. PubMed ID: 18811956
[TBL] [Abstract][Full Text] [Related]
96. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
[TBL] [Abstract][Full Text] [Related]
97. [Construction of pGL3-hTERT-tk recombinant plasmid and effect of PEG-PEI/Fe(3)0(4) Nano-magnetic fluid-tk/GCV on proliferation of gastric cancer cells BGC823 in vitro].
Buduwaili WS; Li L; Zhang BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jul; 15(7):727-31. PubMed ID: 22851080
[TBL] [Abstract][Full Text] [Related]
98. A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.
Yan C; Wen-Chao L; Hong-Yan Q; Rui Z; Wei-Lin J; Hua H
Acta Oncol; 2007; 46(6):773-81. PubMed ID: 17653900
[TBL] [Abstract][Full Text] [Related]
99. Adenovirus-mediated and tumor-specific transgene expression of the sodium-iodide symporter from the human telomerase reverse transcriptase promoter enhances killing of lung cancer cell line in vitro.
Shi YZ; Zhang J; Liu ZL; Du SY; Shen YM
Chin Med J (Engl); 2010 Aug; 123(15):2070-6. PubMed ID: 20819544
[TBL] [Abstract][Full Text] [Related]
100. Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy.
Gao Y; Ng SS; Chau DH; Yao H; Yang C; Man K; Huang PT; Huang C; Huang JJ; Kung HF; Lin MC
Cancer Gene Ther; 2008 Nov; 15(11):723-32. PubMed ID: 18535618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
